{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:40:44Z","timestamp":1792197644041,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03566-5","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:02:19Z","timestamp":1792173739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vilazodone Hydrochloride-Loaded Nanostructured Lipid Carrier In Situ Gel for Intranasal Nose-to-Brain Antidepressant Delivery"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3086-8895","authenticated-orcid":false,"given":"Khushi","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1784-9508","authenticated-orcid":false,"given":"Rajeshkumar S.","family":"Palva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4544-6877","authenticated-orcid":false,"given":"Mitali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-8154","authenticated-orcid":false,"given":"Musaratafrin","family":"Saiyed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7859-8180","authenticated-orcid":false,"given":"Nisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9363-3639","authenticated-orcid":false,"given":"Hardik","family":"Zala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7084-7313","authenticated-orcid":false,"given":"Rajnikant M.","family":"Suthar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0232-0628","authenticated-orcid":false,"given":"Krunal","family":"Detholia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"3566_CR1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116564","volume":"275","author":"J Zheng","year":"2024","unstructured":"Zheng J, Liu Y, Wang X, et al. Design, synthesis and biological evaluation of multimodal serotonergic agents related to vilazodone. Eur J Med Chem. 2024;275:116673.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"3566_CR2","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030629","volume":"14","author":"TP Crowe","year":"2022","unstructured":"Crowe TP, Hsu WH. Evaluation of recent intranasal drug delivery systems to the central nervous system. Pharmaceutics. 2022;14(3):629.","journal-title":"Pharmaceutics"},{"issue":"7","key":"3566_CR3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev. 2012;64(7):614\u201328.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"3566_CR4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","volume":"10","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi CV, Belgamwar VS. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood\u2013brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv. 2013;10(7):957\u201372.","journal-title":"Expert Opin Drug Deliv"},{"key":"3566_CR5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126011","volume":"683","author":"VV Sugandhi","year":"2025","unstructured":"Sugandhi VV, Gattu K, Mundrathi V, Khairnar R, Arshad T, Kumar S, et al. Intranasal delivery of rapamycin via brain-targeting polymeric micelles for Alzheimer\u2019s disease treatment. Int J Pharm. 2025;683:126011.","journal-title":"Int J Pharm"},{"issue":"2","key":"3566_CR6","doi-asserted-by":"crossref","DOI":"10.3390\/gels7020063","volume":"7","author":"B Stawicki","year":"2021","unstructured":"Stawicki B, Schacher T, Cho H. Nanogels as a versatile drug delivery system for brain cancer. Gels. 2021;7(2):63.","journal-title":"Gels"},{"issue":"3","key":"3566_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/2045125311409486","volume":"1","author":"TL Schwartz","year":"2011","unstructured":"Schwartz TL, Siddiqui UA, Stahl SM. Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor. Ther Adv Psychopharmacol. 2011;1(3):81\u20137.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"1","key":"3566_CR8","first-page":"18","volume":"14","author":"SM Wang","year":"2016","unstructured":"Wang SM, Han C, Lee SJ, Jun TY, Patkar AA, Masand PS, et al. Vilazodone for the treatment of depression: an update. Clin Psychopharmacol Neurosci. 2016;14(1):18\u201328.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"3566_CR9","volume":"16","author":"KA Pierz","year":"2014","unstructured":"Pierz KA, Thase ME. A review of vilazodone, serotonin, and major depressive disorder. Prim Care Companion CNS Disord. 2014;16(1):PCC.13r01576.","journal-title":"Prim Care Companion CNS Disord"},{"issue":"8","key":"3566_CR10","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.xphs.2018.04.007","volume":"107","author":"H Abbas","year":"2018","unstructured":"Abbas H, Refai H, El Sayed N. Superparamagnetic iron oxide-loaded lipid nanocarriers incorporated in thermosensitive in situ gel for magnetic brain targeting of clonazepam. J Pharm Sci. 2018;107(8):2119\u201327.","journal-title":"J Pharm Sci"},{"issue":"1\u20133","key":"3566_CR11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","volume":"87","author":"L Illum","year":"2003","unstructured":"Illum L. Nasal drug delivery\u2014possibilities, problems and solutions. J Control Release. 2003;87(1\u20133):187\u201398.","journal-title":"J Control Release"},{"issue":"6","key":"3566_CR12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.apsb.2014.10.005","volume":"4","author":"M Yasir","year":"2014","unstructured":"Yasir M, Sara UVS. Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation. Acta Pharm Sin B. 2014;4(6):454\u201363.","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"3566_CR13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/jps.10371","volume":"92","author":"AH Krauland","year":"2003","unstructured":"Krauland AH, Leitner VM, Bernkop-Schn\u00fcrch A. Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups. J Pharm Sci. 2003;92(6):1234\u201341.","journal-title":"J Pharm Sci"},{"issue":"3","key":"3566_CR14","first-page":"168","volume":"7","author":"NGN Swamy","year":"2012","unstructured":"Swamy NGN, Abbas Z. Mucoadhesive in situ gels as nasal drug delivery systems: an overview. Asian J Pharm Sci. 2012;7(3):168\u201380.","journal-title":"Asian J Pharm Sci"},{"issue":"7","key":"3566_CR15","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03209-1","volume":"26","author":"H Mahajan","year":"2025","unstructured":"Mahajan H, Nirbhavane P, Chalikwar S, Moravkar KK. In situ nanolipoidal gel of stiripentol for intranasal administration: preclinical evidence of enhanced biopharmaceutical and therapeutic outcomes. AAPS PharmSciTech. 2025;26(7):220.","journal-title":"AAPS PharmSciTech"},{"key":"3566_CR16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118918","volume":"576","author":"AB Kova\u010devi\u0107","year":"2020","unstructured":"Kova\u010devi\u0107 AB, M\u00fcller RH, Keck CM. Formulation development of lipid nanoparticles: improved lipid screening and development of tacrolimus-loaded nanostructured lipid carriers (NLC). Int J Pharm. 2020;576:118918.","journal-title":"Int J Pharm"},{"issue":"2","key":"3566_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1208\/s12249-009-9216-3","volume":"10","author":"PF Yue","year":"2009","unstructured":"Yue PF, Yuan HL, Zhu WF, Li Y, Wang CH, Wang F, et al. The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion. AAPS PharmSciTech. 2009;10(2):376\u201383.","journal-title":"AAPS PharmSciTech"},{"key":"3566_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12247-025-10204-3","volume":"20","author":"R Palva","year":"2025","unstructured":"Palva R, Lobo F, Suthar R, et al. Novel liposomal nanocarrier of dasatinib for enhanced chronic myeloid leukemia treatment: improved pharmacokinetics and reduced toxicity. J Pharm Innov. 2025;20:258.","journal-title":"J Pharm Innov"},{"issue":"1","key":"3566_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s11671-025-04276-w","volume":"20","author":"SA Khan","year":"2025","unstructured":"Khan SA, Qamar Z, Kamboj S, Moonis M, Rai G, Dang S, et al. Nose to brain delivery of nanostructured lipid carriers loaded with rivastigmine and nilotinib for treating Alzheimer\u2019s disease: preparation, cell line study, and in vivo evaluation. Discov Nano. 2025;20(1):93.","journal-title":"Discov Nano"},{"issue":"sup1","key":"3566_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/21691401.2017.1408124","volume":"46","author":"K Soni","year":"2018","unstructured":"Soni K, Rizwanullah MD, Kohli K. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box\u2013Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments. Artif Cells Nanomed Biotechnol. 2018;46(sup1):15\u201331.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"9","key":"3566_CR21","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.52711\/0974-360X.2023.00707","volume":"16","author":"B Behera","year":"2023","unstructured":"Behera B, Mishra US, Sahoo SK. Development and validation of stability indicating RP-HPLC method for the analysis of vilazodone in bulk form and marketed pharmaceutical dosage form. Res J Pharm Technol. 2023;16(9):4319\u201324.","journal-title":"Res J Pharm Technol"},{"issue":"1","key":"3566_CR22","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1515\/ntrev-2022-0109","volume":"11","author":"S Javed","year":"2022","unstructured":"Javed S, Mangla B, Almoshari Y, Sultan MH, Ahsan W. Nanostructured lipid carrier system: a compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnol Rev. 2022;11(1):1744\u201377.","journal-title":"Nanotechnol Rev"},{"key":"3566_CR23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejpb.2022.02.010","volume":"172","author":"R Varela-Fern\u00e1ndez","year":"2022","unstructured":"Varela-Fern\u00e1ndez R, Garc\u00eda-Otero X, D\u00edaz-Tom\u00e9 V, Regueiro U, L\u00f3pez-L\u00f3pez M, Gonz\u00e1lez-Barcia M, et al. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery. Eur J Pharm Biopharm. 2022;172:144\u201356.","journal-title":"Eur J Pharm Biopharm"},{"key":"3566_CR24","volume-title":"Response surface methodology: process and product optimization using designed experiments","author":"RH Myers","year":"2016","unstructured":"Myers RH, Montgomery DC, Anderson-Cook CM. Response surface methodology: process and product optimization using designed experiments. 4th ed. Hoboken: Wiley; 2016.","edition":"4th ed"},{"issue":"1","key":"3566_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2517-6161.1951.tb00067.x","volume":"13","author":"GE Box","year":"1951","unstructured":"Box GE, Wilson KB. On the experimental attainment of optimum conditions. J R Stat Soc B. 1951;13(1):1\u201345.","journal-title":"J R Stat Soc B"},{"key":"3566_CR26","unstructured":"ICH. Stability testing of new drug substances and products Q1A(R2). International Council for Harmonisation; 2003."},{"issue":"3","key":"3566_CR27","doi-asserted-by":"crossref","DOI":"10.3390\/jfb13030125","volume":"13","author":"N Montegiove","year":"2022","unstructured":"Montegiove N, Calzoni E, Emiliani C, Cesaretti A. Biopolymer nanoparticles for nose-to-brain drug delivery: a new promising approach for the treatment of neurological diseases. J Funct Biomater. 2022;13(3):125.","journal-title":"J Funct Biomater"},{"issue":"1","key":"3566_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/js9601896","volume":"86","author":"BC Hancock","year":"1997","unstructured":"Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci. 1997;86(1):1\u201312.","journal-title":"J Pharm Sci"},{"issue":"4","key":"3566_CR29","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13040531","volume":"13","author":"AC Ortiz","year":"2021","unstructured":"Ortiz AC, Ya\u00f1ez O, Salas-Huenuleo E, Morales JO. Development of a nanostructured lipid carrier (NLC) by a low-energy method, comparison of release kinetics and molecular dynamics simulation. Pharmaceutics. 2021;13(4):531.","journal-title":"Pharmaceutics"},{"issue":"11","key":"3566_CR30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/ed039p546","volume":"39","author":"RM Silverstein","year":"1962","unstructured":"Silverstein RM, Bassler GC. Spectrometric identification of organic compounds. J Chem Educ. 1962;39(11):546.","journal-title":"J Chem Educ"},{"key":"3566_CR31","first-page":"1","volume":"17","author":"P Datta","year":"2026","unstructured":"Datta P, Katari O, Yadav V, Dhake P, Jain S. Transdermal ionic liquid gel of erlotinib for localized breast cancer therapy. Pharm Res. 2026;17:1\u20137.","journal-title":"Pharm Res"},{"key":"3566_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.poly.2019.02.002","volume":"164","author":"E Sadati Behbahani","year":"2019","unstructured":"Sadati Behbahani E, Ghaedi M, Abbaspour M, Rostamizadeh K, Dashtian K. Curcumin loaded nanostructured lipid carriers: in vitro digestion and release studies. Polyhedron. 2019;164:113\u201322.","journal-title":"Polyhedron"},{"key":"3566_CR33","volume-title":"Elements of X-ray diffraction","author":"BD Cullity","year":"2001","unstructured":"Cullity BD, Stock SR. Elements of X-ray diffraction. 3rd ed. Upper Saddle River: Prentice-Hall; 2001.","edition":"3rd ed"},{"key":"3566_CR34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jddst.2019.01.040","volume":"51","author":"AP Rajput","year":"2019","unstructured":"Rajput AP, Butani SB. Resveratrol anchored nanostructured lipid carrier loaded in situ gel via nasal route: formulation, optimization and in vivo characterization. J Drug Deliv Sci Technol. 2019;51:214\u201323.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3566_CR35","first-page":"18763","volume":"8","author":"MM Ban","year":"2018","unstructured":"Ban MM, Chakote VR, Dhembre GN, Rajguru JR, Joshi DA. In situ gel for nasal drug delivery. Int J Dev Res. 2018;8:18763\u20139.","journal-title":"Int J Dev Res"},{"key":"3566_CR36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpb.2023.01.007","volume":"184","author":"OM Kolawole","year":"2023","unstructured":"Kolawole OM, Cook MT. In situ gelling drug delivery systems for topical drug delivery. Eur J Pharm Biopharm. 2023;184:36\u201349.","journal-title":"Eur J Pharm Biopharm"},{"key":"3566_CR37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1515\/mr-2023-0018","volume":"3","author":"Z Sahin","year":"2023","unstructured":"Sahin Z. Assessment of commonly used tests in experimental depression studies according to behavioral patterns of rodents. Med Rev. 2023;3:526\u201331.","journal-title":"Med Rev"},{"key":"3566_CR38","first-page":"545","volume-title":"Drug discovery and evaluation of pharmacological assays","author":"HG Vogel","year":"2022","unstructured":"Vogel HG, Scholkens AB, Sandow J, Muller G. Drug discovery and evaluation of pharmacological assays. 2nd ed. New York: Springer; 2022. p. 545\u201376.","edition":"2nd ed"},{"key":"3566_CR39","first-page":"134","volume-title":"Screening methods in pharmacology","author":"NS Parmar","year":"2006","unstructured":"Parmar NS, Prakash S. Screening methods in pharmacology. 1st ed. New Delhi: Narosa Publishing House; 2006. p. 134\u201346.","edition":"1st ed"},{"key":"3566_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0985-4","volume":"14","author":"WJ Su","year":"2017","unstructured":"Su WJ, Peng W, Gong H, Liu YZ, Zhang Y, Lian YJ, et al. Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance. J Neuroinflammation. 2017;14:210.","journal-title":"J Neuroinflammation"},{"key":"3566_CR41","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.pharep.2017.04.018","volume":"69","author":"TK Patel","year":"2017","unstructured":"Patel TK, Patel VB, Rana DG. Possible antidepressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice. Pharmacol Rep. 2017;69:1082\u20137.","journal-title":"Pharmacol Rep"},{"key":"3566_CR42","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00210-020-01838-w","volume":"393","author":"E Soliman","year":"2020","unstructured":"Soliman E, Essmat N, Mahmoud MF, Mahmoud AA. Impact of some oral hypoglycemic agents on type 2 diabetes-associated depression and reserpine-induced depression in rats: the role of brain oxidative stress and inflammation. Naunyn Schmiedebergs Arch Pharmacol. 2020;393:1391\u2013404.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"3566_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2011.01.007","volume":"78","author":"RH M\u00fcller","year":"2011","unstructured":"M\u00fcller RH, Shegokar R, Keck CM. 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Eur J Pharm Biopharm. 2011;78(1):1\u20139.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"3566_CR44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"J Pardeike","year":"2009","unstructured":"Pardeike J, Hommoss A, M\u00fcller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1\u20132):170\u201384.","journal-title":"Int J Pharm"},{"issue":"1","key":"3566_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","volume":"11","author":"L Illum","year":"2000","unstructured":"Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 2000;11(1):1\u201318.","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20132","key":"3566_CR46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","volume":"242","author":"RH M\u00fcller","year":"2002","unstructured":"M\u00fcller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 2002;242(1\u20132):121\u20138.","journal-title":"Int J Pharm"},{"issue":"3","key":"3566_CR47","first-page":"401","volume":"73","author":"S Doktorovova","year":"2009","unstructured":"Doktorovova S, Souto EB. Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review. Eur J Pharm Biopharm. 2009;73(3):401\u201310.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2\u20133","key":"3566_CR48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-3659(99)00223-0","volume":"66","author":"V Jenning","year":"2000","unstructured":"Jenning V, Gysler A, Sch\u00e4fer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. J Control Release. 2000;66(2\u20133):115\u201326.","journal-title":"J Control Release"},{"key":"3566_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","volume":"64","author":"W Mehnert","year":"2012","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2012;64:83\u2013101.","journal-title":"Adv Drug Deliv Rev"},{"issue":"15","key":"3566_CR50","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","volume":"58","author":"W Abdelwahed","year":"2006","unstructured":"Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58(15):1688\u2013713.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"3566_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2420001","volume":"242","author":"JH Crowe","year":"1987","unstructured":"Crowe JH, Crowe LM, Carpenter JF, Wistrom CA. Stabilization of dry phospholipid bilayers and proteins by sugars. Biochem J. 1987;242(1):1\u201310.","journal-title":"Biochem J"},{"issue":"4","key":"3566_CR52","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","volume":"13","author":"P Ghasemiyeh","year":"2018","unstructured":"Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems. Res Pharm Sci. 2018;13(4):288\u2013303.","journal-title":"Res Pharm Sci"},{"issue":"1\u20132","key":"3566_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0927-7757(94)03028-X","volume":"96","author":"P Alexandridis","year":"1995","unstructured":"Alexandridis P, Hatton TA. Poly(ethylene oxide)\u2013poly(propylene oxide)\u2013poly(ethylene oxide) block copolymer surfactants in aqueous solutions. Colloids Surf A. 1995;96(1\u20132):1\u201346.","journal-title":"Colloids Surf A"},{"issue":"12","key":"3566_CR54","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","volume":"23","author":"G Dumortier","year":"2006","unstructured":"Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23(12):2709\u201328.","journal-title":"Pharm Res"},{"issue":"2","key":"3566_CR55","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2004.03.019","volume":"58","author":"E Ruel-Gari\u00e9py","year":"2004","unstructured":"Ruel-Gari\u00e9py E, Leroux JC. In situ-forming hydrogels\u2014review of temperature-sensitive systems. Eur J Pharm Biopharm. 2004;58(2):409\u201326.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"3566_CR56","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/0110-5558.76436","volume":"1","author":"BM Boddupalli","year":"2010","unstructured":"Boddupalli BM, Mohammed ZN, Nath RA, Banji D. Mucoadhesive drug delivery system: an overview. J Adv Pharm Technol Res. 2010;1(4):381\u20137.","journal-title":"J Adv Pharm Technol Res"},{"issue":"6","key":"3566_CR57","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jbm.820060609","volume":"6","author":"IR Schmolka","year":"1972","unstructured":"Schmolka IR. Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res. 1972;6(6):571\u201382.","journal-title":"J Biomed Mater Res"},{"key":"3566_CR58","doi-asserted-by":"crossref","unstructured":"Thorne RG, Pronk GJ, Padmanabhan V, Frey WH II. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 2004;127(2):481\u201396.","DOI":"10.1016\/j.neuroscience.2004.05.029"},{"key":"3566_CR59","doi-asserted-by":"crossref","unstructured":"Dhuria SV, Hanson LR, Frey WH II. Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. J Pharm Sci. 2010;99(4):1654\u201373.","DOI":"10.1002\/jps.21924"},{"issue":"4","key":"3566_CR60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1166\/jbn.2007.049","volume":"3","author":"EB Souto","year":"2007","unstructured":"Souto EB, Almeida AJ, M\u00fcller RH. J Biomed Nanotechnol. 2007;3(4):317\u201331.","journal-title":"J Biomed Nanotechnol"},{"issue":"1\u20132","key":"3566_CR61","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2014.04.015","volume":"468","author":"S Qian","year":"2014","unstructured":"Qian S, Wong YC, Zuo Z. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine. Int J Pharm. 2014;468(1\u20132):272\u201382.","journal-title":"Int J Pharm"},{"issue":"Suppl 3","key":"3566_CR62","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","volume":"9","author":"LR Hanson","year":"2008","unstructured":"Hanson LR, Frey WH. Intranasal delivery bypasses the blood\u2013brain barrier to target therapeutic agents to the central nervous system. BMC Neurosci. 2008;9(Suppl 3):S5.","journal-title":"BMC Neurosci"},{"issue":"2","key":"3566_CR63","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02736-7","volume":"25","author":"D Sonawane","year":"2024","unstructured":"Sonawane D, Pokharkar V. Quercetin-loaded nanostructured lipid carrier in situ gel for brain targeting through intranasal route: formulation, in vivo pharmacokinetic and pharmacodynamic studies. AAPS PharmSciTech. 2024;25(2):30.","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"3566_CR64","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02954-z","volume":"25","author":"K Akbar","year":"2024","unstructured":"Akbar K, Rehman MU, Shah FA, Younas S, Al-Otaibi JS, Khan H. Paroxetine loaded nanostructured lipid carriers based in-situ gel for brain delivery via nasal route for enhanced anti-depressant effect: in vitro prospect and in vivo efficacy. AAPS PharmSciTech. 2024;25(8):248.","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"3566_CR65","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071985","volume":"15","author":"D Mohanty","year":"2023","unstructured":"Mohanty D, Alsaidan OA, Zafar A, Dodle T, Gupta JK, Yasir M, et al. Development of atomoxetine-loaded NLC in situ gel for nose-to-brain delivery: optimization, in vitro, and preclinical evaluation. Pharmaceutics. 2023;15(7):1985.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3566_CR66","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03313-2","volume":"27","author":"NR Jadhav","year":"2026","unstructured":"Jadhav NR, Yede SR, Jadhav AS, Mane MN, Patil PS, Mohite SS. Optimization of ionic liquid based NLC for nose-to-brain delivery of tetrabenazine hydrochloride. AAPS PharmSciTech. 2026;27(1):69.","journal-title":"AAPS PharmSciTech"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03566-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03566-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03566-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:56:38Z","timestamp":1792194998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03566-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":66,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3566"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03566-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"17 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"329"}}